ESMO Guidelines: Real World Cases - Webinar Series
This Webinar series brings together all the relevant stakeholders who are developing each guideline, as well as those who are consulting and implementing the guideline.
ESMO Webinar Series
Online educational programmes delivered by the world’s top leaders in oncology, freely available to all ESMO members.
- New ESMO Webinar platform freely available all healthcare professionals working in Oncology
- Watch the live broadcast or on-demand at a later date
- View anywhere in the world with an internet connection
- Submit questions to the faculty for answering
- Pre and Post webinar knowledge testing
- PC, Mac, tablet and smartphone compatible
SARS-CoV-2 Vaccination: Special Considerations in Patients with Cancer
This Webinar Series is developed with the aim to disseminate the ESMO position on the protection through the SARS-CoV-2 vaccination as a public health priority and provide some important considerations for patients with cancer.
Will Recent Major Trials With CDK Inhibitors Be Practice Changing In Early Breast Cancer?
The programme is designed to offer an overview of recent research activities in this area and review the current status and future prospect of CDK4-6 inhibitors in HR-positive/HER2-negative early breast cancer.
Testing and Targeting Tumours with RET Alterations
The programme is designed to offer an overview of research activities in this area and review the current status and future prospect of testing and targeting various tumours with RET alterations.
CDK 4-6 Inhibitors in Breast Cancer
The programme is designed to offer an overview of research activities in this area and review the current status and future prospects of CDK4-6 inhibitors in breast cancer.
Managing Patients in the COVID-19 Era
This Webinar series has been organised with the aim to share the ESMO adapted recommendations for cancer patient management during the COVID-19 pandemic.
Immune Checkpoint Inhibitors in HNSCC: Changing the Treatment Landscape
The programme is designed to offer an overview of research in this area and review the current status and future prospects of immunotherapy in HNSCC.
Translating Immunity to Clinical Applications of Immunotherapy in Breast Cancer
The programme is designed to offer an overview of research in this area and review the current status and future prospects of immunotherapy in breast cancer.